AdvertisementSupported byBusiness BriefingBy The Associated PressSanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the lifesaving drug. The recall includes all Auvi-Q injections on the United States market, or roughly 490,000 packs of the devices, the company says. The injectors, a staple of first-aid care, are used to treat allergic reactions from insect bites, foods, medicines or other substances. Sanofi estimates about 200,000 people in the United States have its injector. Advertisement